|
Market Closed -
London S.E.
19:35:12 20/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 8.500 GBX | +9.68% |
|
+9.68% | -27.66% |
| 10-20 | Ixico stock rises as forecasts full-year revenue and earnings beat | AN |
| 10-20 | WINNERS & LOSERS: Ixico beats expectations; Shearwater wins deal | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 22.6M | - | ||||
| 65.83B | |||||
| 51.87B | |||||
| 51.2B | |||||
| 43.76B | |||||
| 42.09B |
- Stock Market
- Stocks
- IXI Stock
- Charts IXICO plc
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
